ESC Premium Access

Discussion & summary - A novel approach for high CV risk patients with diabetes: the potential of epigenetics.

Topic: Primary cardiovascular prevention: interventions and outcomes
Organised by Academic Medical Center Amsterdam. Dept Vascular Medicine and Physicians' Academy for Cardiovascular Education / Course Director: Prof John Kastelein / Supported by an unrestricted educational grant from Resverlogix

Congress Presentation

About the speakers

Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
79 presentations
12 followers

Professor Stefano Del Prato

University of Pisa, Pisa (Italy)
8 presentations
0 follower

4 more presentations in this session

Introduction - A novel approach for high CV risk patients with diabetes: the potential of epigenetics.

Speaker: Professor S. Del Prato (Pisa, IT)

Thumbnail

The high risk diabetes patient with cardiovascular disease: what else can we target to reduce cardiovascular risk?

Speaker: Professor K. Ray (London, GB)

Thumbnail

Understanding BET inhibition as a novel pathway for cardiovascular risk modulation.

Speaker: Doctor J. Plutzky (Boston, US)

Thumbnail

BET inhibition in cardiovascular disease: a new dawn?

Speaker: Professor J. Kastelein (Amsterdam, NL)

Thumbnail

Access the full session

A novel approach for high CV risk patients with diabetes: the potential of epigenetics

Speakers: Professor K. Ray, Professor S. Del Prato, Professor S. Del Prato, Professor K. Ray, Doctor J. Plutzky...
Thumbnail

About the event

Image

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb